Trial Profile
Effect of Eculizumab in patients with post transplant Atypical Hemolytic Uremic Syndrome who had received non-renal solid organ transplant
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Apr 2015
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Atypical Haemolytic Uraemic Syndrome
- Focus Therapeutic Use
- 16 Apr 2015 New trial record